The HIV-TSG101 interface: Recent advances in a budding field

Trends in Microbiology

Volumn 11, Issue 2, 2003, Pages 56-59

  Freed, Eric O ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; ISOPROTEIN; PEPTIDE; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

BINDING SITE; ENDOSOME; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; VIRUS ASSEMBLY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES;

EID: 0037321831     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(02)00013-6     Document Type: Short Survey

References (25)

1. Freed E.O. HIV-1 Gag proteins: diverse functions in the virus life cycle. Virology. 251:1998;1-15.
2. Gottlinger H.G., et al. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. U. S. A. 88:1991;3195-3199.
3. Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69:1995;6810-6818.
4. Demirov D.G., et al. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner. J. Virol. 76:2002;105-117.
5. Freed E.O. Viral late domains. J. Virol. 76:2002;4679-4687.
6. Pornillos O., et al. Mechanisms of enveloped RNA virus budding. Trends Cell Biol. 12:2002;569-579.
7. Gag protein of Moloney murine leukemia virus. J. Virol. 72:1998;2962-2968.
8. van Kerkhof P., et al. Endocytosis and degradation of the growth hormone receptor are proteasome-dependent. J. Biol. Chem. 275:2000;1575-1580.
9. Longva K.E., et al. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J. Cell Biol. 156:2002;843-854.
10. Schubert U., et al. Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. U. S. A. 97:2000;13057-13062.
11. Strack B., et al. A role for ubiquitin ligase recruitment in retrovirus release. Proc. Natl. Acad. Sci. U. S. A. 97:2000;13063-13068.
12. Gag . Proc. Natl. Acad. Sci. U. S. A. 98:2001;7724-7729.
13. Garrus J.E., et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell. 107:2001;55-65.
14. Martin-Serrano J., et al. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7:2001;1313-1319.
15. Demirov D.G., et al. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. U. S. A. 99:2002;955-960.
16. Babst M., et al. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic. 1:2000;248-258.
17. Lemmon S.K., Traub L.M. Sorting in the endosomal system in yeast and animal cells. Curr. Opin. Cell Biol. 12:2000;457-466.
18. Katzmann D.J., et al. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell. 106:2001;145-155.
19. Bishop N., et al. Mammalian class E vps proteins recognize ubiquitin and act in the removal of endosomal protein-ubiquitin conjugates. J. Cell Biol. 157:2002;91-101.
20. Pornillos O., et al. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat. Struct. Biol. 9:2002;812-817.
21. Pornillos O., et al. Structure and functional interactions of the Tsg101 UEV domain. EMBO J. 21:2002;2397-2406.
22. Zarrinpar A., Lim W.A. Converging on proline: the mechanism of WW domain peptide recognition. Nat. Struct. Biol. 7:2000;611-613.
23. Nguyen J.T., et al. Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. Science. 282:1998;2088-2092.
24. Huang X., et al. Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan. Nat. Struct. Biol. 7:2000;634-638.
25. Wittekind M., et al. Solution structure of the Grb2 N-terminal SH3 domain complexed with a ten-residue peptide derived from SOS: direct refinement against NOEs, J-couplings and 1H and 13C chemical shifts. J. Mol. Biol. 267:1997;933-952.